Manufacturer record
Mercury Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Mercury Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between October 2025 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
7 records linked to Mercury Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24097Mfg 2024-09 · Exp 2026-02 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24120Mfg 2024-11 · Exp 2026-04 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24099Mfg 2024-09 · Exp 2026-02 | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24122Mfg 2024-11 · Exp 2026-04 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24119Mfg 2024-11 · Exp 2026-04 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24098Mfg 2024-09 · Exp 2026-02 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24121Mfg 2024-11 · Exp 2026-04 | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.